Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingjiang Ye

Showing results (201-210 of 220) with videos related to

Pageof 22
Sort By:
European Radiology|November 30, 2022
Risk stratification for 1- to 2-cm gastric gastrointestinal stromal tumors: visual assessment of CT and EUS high-risk features versus CT radiomics analysisXiaoxuan Jia, Lijuan Wan, Xiaoshan Chen, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 27, 2017
Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumorJian Li, Yingjiang Ye, Jian Wang, et al.
Nature Medicine|January 6, 2025
Neoadjuvant chemoradiation with or without PD-1 blockade in locally advanced rectal cancer: a randomized phase 2 trialYingchi Yang, Kai Pang, Guole Lin, et al.
International Journal of Colorectal Disease|January 4, 2021
Multicenter investigation of bowel evacuation function after transanal total mesorectal excision for mid-low rectal cancerZhanlong Shen, Gang Yu, Mingyang Ren, et al.
Lancet (London, England)|June 1, 2026
Perioperative serplulimab with neoadjuvant chemotherapy versus perioperative chemotherapy in PD-L1-positive gastric cancer (ASTRUM-006): a randomised, double-blind, multicentre, phase 3 studyLin Shen, Xiaotian Zhang, Ke Ji, et al.
The Lancet. Oncology|February 15, 2021
Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trialLai Xu, Xiangqian Su, Zirui He, et al.
Journal of Hematology & Oncology|April 8, 2024
Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trialXinxin Wang, Canrong Lu, Bo Wei, et al.
Oncotarget|October 31, 2015
Genome-wide association study identifies two new susceptibility loci for colorectal cancer at 5q23.3 and 17q12 in Han ChineseKewei Jiang, Yimin Sun, Cheng Wang, et al.
Surgical Endoscopy|November 25, 2020
Robotic colorectal cancer surgery in China: a nationwide retrospective observational studyJianmin Xu, Bo Tang, Taiyuan Li, et al.
Cell|April 18, 2020
Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon CancerLei Zhang, Ziyi Li, Katarzyna M Skrzypczynska, et al.
Pageof 22

Showing results (201-210 of 220) with videos related to

Sort By:
Pageof 22
European Radiology|November 30, 2022
Risk stratification for 1- to 2-cm gastric gastrointestinal stromal tumors: visual assessment of CT and EUS high-risk features versus CT radiomics analysisXiaoxuan Jia, Lijuan Wan, Xiaoshan Chen, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 27, 2017
Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumorJian Li, Yingjiang Ye, Jian Wang, et al.
Nature Medicine|January 6, 2025
Neoadjuvant chemoradiation with or without PD-1 blockade in locally advanced rectal cancer: a randomized phase 2 trialYingchi Yang, Kai Pang, Guole Lin, et al.
International Journal of Colorectal Disease|January 4, 2021
Multicenter investigation of bowel evacuation function after transanal total mesorectal excision for mid-low rectal cancerZhanlong Shen, Gang Yu, Mingyang Ren, et al.
Lancet (London, England)|June 1, 2026
Perioperative serplulimab with neoadjuvant chemotherapy versus perioperative chemotherapy in PD-L1-positive gastric cancer (ASTRUM-006): a randomised, double-blind, multicentre, phase 3 studyLin Shen, Xiaotian Zhang, Ke Ji, et al.
The Lancet. Oncology|February 15, 2021
Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trialLai Xu, Xiangqian Su, Zirui He, et al.
Journal of Hematology & Oncology|April 8, 2024
Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trialXinxin Wang, Canrong Lu, Bo Wei, et al.
Oncotarget|October 31, 2015
Genome-wide association study identifies two new susceptibility loci for colorectal cancer at 5q23.3 and 17q12 in Han ChineseKewei Jiang, Yimin Sun, Cheng Wang, et al.
Surgical Endoscopy|November 25, 2020
Robotic colorectal cancer surgery in China: a nationwide retrospective observational studyJianmin Xu, Bo Tang, Taiyuan Li, et al.
Cell|April 18, 2020
Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon CancerLei Zhang, Ziyi Li, Katarzyna M Skrzypczynska, et al.
Pageof 22